E3 PreliminaryPreliminaryPEM not requiredMechanisticPeer-reviewedReviewed
Standard · 3 min
Xpr1 is an atypical G-protein-coupled receptor that mediates xenotropic and polytropic murine retrovirus neurotoxicity.
Vaughan, Andrew E, Mendoza, Ramon, Aranda, Ramona et al. · Journal of virology · 2012 · DOI
Quick Summary
This study explored how a virus called XMRV might damage nerve cells in people with ME/CFS. Researchers found that when this virus enters cells, it blocks an important communication system (called cAMP signaling) that normally keeps cells healthy, leading them to die. However, it's now known that XMRV detection in human samples was likely due to contamination rather than actual infection.
Why It Matters
This mechanistic study provided a plausible biological explanation for how a retrovirus could cause neurological damage in ME/CFS patients, specifically through disruption of critical cellular signaling pathways. Understanding retrovirus-induced neuronal toxicity mechanisms could inform future investigations into viral triggers of neuroinflammatory diseases, even if XMRV itself is not the causative agent in humans.
Observed Findings
XMRV infection induced apoptosis in human neuroblastoma cells in a dose- or time-dependent manner.
Xpr1 is associated with the Gβ subunit of G-protein heterotrimers and functions as a GPCR.
XMRV binding to Xpr1 reduces cAMP signaling and activates apoptotic pathways.
Xpr1 does not function in phosphate uptake, distinguishing it from structurally similar proteins.
Inferred Conclusions
XMRV-induced neurotoxicity occurs through disruption of cAMP-mediated signaling via the Xpr1 GPCR.
Xpr1 represents a novel atypical GPCR with signaling functions distinct from transport functions.
The cAMP disruption mechanism is conserved across xenotropic and polytropic retroviruses (including MCF virus).
Retroviral binding to Xpr1 may represent a general mechanism of retrovirus-induced neuronal damage.
Remaining Questions
Does this cAMP disruption mechanism occur in other cell types relevant to ME/CFS, such as immune cells or glial cells?
What This Study Does Not Prove
This study does not prove that XMRV causes ME/CFS in humans, as subsequent evidence showed XMRV detection was contamination. It also does not establish that this toxicity mechanism applies to other retroviruses potentially involved in ME/CFS, nor does it demonstrate that blocking this pathway would reverse ME/CFS symptoms in patients.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.